Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Miller

Showing results (121-130 of 138) with videos related to

Pageof 14
Sort By:
JMIR Research Protocols|September 6, 2022
Proactive, Recovery-Oriented Treatment Navigation to Engage Racially Diverse Veterans in Mental Healthcare (PARTNER-MH), a Peer-Led Patient Navigation Intervention for Racially and Ethnically Minoritized Veterans in Veterans Health Administration Mental Health Services: Protocol for a Mixed Methods Randomized Controlled Feasibility StudyJohanne Eliacin, Diana J Burgess, Angela L Rollins, et al.
Neurology|March 3, 2017
Genetic heterogeneity of motor neuropathiesBoglarka Bansagi, Helen Griffin, Roger G Whittaker, et al.
Neuro-Oncology Practice|September 16, 2024
Preoperative stereotactic radiosurgery for patients with 1-4 brain metastases: A single-arm phase 2 trial outcome analysis (NCT03398694)Namita Agrawal, Jack M Shireman, Kevin Shiue, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 11, 2025
Efgartigimod efficacy and safety in refractory myasthenia gravis: UK's first real-world experienceJoana Moniz Dionísio, Philip Ambrose, Georgina Burke, et al.
Brain : a Journal of Neurology|December 28, 2010
A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophyDebbie Hicks, Anna Sarkozy, Nuria Muelas, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 21, 2018
Extending the clinical and mutational spectrum of <i>TRIM32</i>-related myopathies in a non-Hutterite populationKatherine Johnson, Willem De Ridder, Ana Töpf, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 7, 2019
Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID studyChristine Verboon, Bianca van den Berg, David R Cornblath, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2023
Genomic Analysis of Human Brain Metastases Treated with Stereotactic Radiosurgery Under the Phase-II Clinical Trial (NCT03398694) Reveals DNA Damage Repair at the Peripheral Tumor EdgeJack M Shireman, Quinn White, Namita Agrawal, et al.
Iscience|April 16, 2024
Genomic analysis of human brain metastases treated with stereotactic radiosurgery reveals unique signature based on treatment failureJack M Shireman, Quinn White, Zijian Ni, et al.
Environment International|December 22, 2015
Implementing systematic review techniques in chemical risk assessment: Challenges, opportunities and recommendationsPaul Whaley, Crispin Halsall, Marlene Ågerstrand, et al.
Pageof 14

Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
JMIR Research Protocols|September 6, 2022
Proactive, Recovery-Oriented Treatment Navigation to Engage Racially Diverse Veterans in Mental Healthcare (PARTNER-MH), a Peer-Led Patient Navigation Intervention for Racially and Ethnically Minoritized Veterans in Veterans Health Administration Mental Health Services: Protocol for a Mixed Methods Randomized Controlled Feasibility StudyJohanne Eliacin, Diana J Burgess, Angela L Rollins, et al.
Neurology|March 3, 2017
Genetic heterogeneity of motor neuropathiesBoglarka Bansagi, Helen Griffin, Roger G Whittaker, et al.
Neuro-Oncology Practice|September 16, 2024
Preoperative stereotactic radiosurgery for patients with 1-4 brain metastases: A single-arm phase 2 trial outcome analysis (NCT03398694)Namita Agrawal, Jack M Shireman, Kevin Shiue, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 11, 2025
Efgartigimod efficacy and safety in refractory myasthenia gravis: UK's first real-world experienceJoana Moniz Dionísio, Philip Ambrose, Georgina Burke, et al.
Brain : a Journal of Neurology|December 28, 2010
A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophyDebbie Hicks, Anna Sarkozy, Nuria Muelas, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 21, 2018
Extending the clinical and mutational spectrum of <i>TRIM32</i>-related myopathies in a non-Hutterite populationKatherine Johnson, Willem De Ridder, Ana Töpf, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 7, 2019
Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID studyChristine Verboon, Bianca van den Berg, David R Cornblath, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2023
Genomic Analysis of Human Brain Metastases Treated with Stereotactic Radiosurgery Under the Phase-II Clinical Trial (NCT03398694) Reveals DNA Damage Repair at the Peripheral Tumor EdgeJack M Shireman, Quinn White, Namita Agrawal, et al.
Iscience|April 16, 2024
Genomic analysis of human brain metastases treated with stereotactic radiosurgery reveals unique signature based on treatment failureJack M Shireman, Quinn White, Zijian Ni, et al.
Environment International|December 22, 2015
Implementing systematic review techniques in chemical risk assessment: Challenges, opportunities and recommendationsPaul Whaley, Crispin Halsall, Marlene Ågerstrand, et al.
Pageof 14